Control Particles for Microvesicle Nucleic Acid Extraction Quality
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating microvesicles and extracting nucleic acids lack consistency and reliability, leading to inconsistent results in diagnostic analyses, particularly in clinical settings where invasive tissue biopsies are not feasible.
Innovation Solution
The use of control particles, such as Q-beta bacteriophage, is introduced as an internal control to assess the quality of microvesicle isolation and nucleic acid extraction by adding them to biological samples, allowing for the calculation of their recovery rates and determining if they fall within predetermined ranges, ensuring high-quality samples for further analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If microvesicles are isolated and nucleic acids are extracted from biological samples for diagnostic analysis, then diagnostic information can be obtained, but the results are inconsistent and unreliable without proper controls
Solution Approach 1:
Control particles are introduced as intermediary elements that mediate between the extraction process and quality assessment. These particles serve as a reference standard that interacts with the same extraction procedures as the target microvesicles, enabling indirect measurement of extraction efficiency and consistency through comparison of control versus target recovery rates
Solution Approach 2:
The method implements feedback by measuring the recovery rate of control particles and using this information to assess and adjust the quality of nucleic acid extraction. The control particle measurement provides feedback about process consistency, allowing identification of failed or suboptimal extractions before diagnostic analysis proceeds
2Ease of operation
If invasive tissue biopsies are avoided in favor of microvesicle analysis from bodily fluids, then patient welfare is improved and longitudinal monitoring is enabled, but the quality control of extracted nucleic acids becomes more challenging
Solution Approach 1:
Control particles act as intermediary quality markers that travel through the same sample collection and extraction process as the diagnostic microvesicles. This allows quality assessment of easily collected bodily fluid samples without requiring invasive procedures, maintaining both ease of operation and reliability
Solution Approach 2:
The control particles perform self-service quality verification by inherently participating in the extraction process and providing built-in reference measurements. This self-contained quality control mechanism enables autonomous assessment of sample quality without requiring separate control procedures
Data Source
AI summary
The present invention features a method and kit for isolating microvesicles or extracting microvesicle nucleic acids from a biological sample by using a control particle. The present invention provides control particles that are viruses or virus-like particles, such as bacteriophages, that contain control nucleic acids that can be detected to assess the accuracy, reliability, and efficiency of the microvesicle isolation or nucleic acid extraction steps. The methods described herein may further comprise the analysis of the presence, absence, or level of at least one biomarker associated with a disease or medical condition for diagnosing, prognosing, or monitoring the disease or medical condition.